ADRIAMYCIN, VINCRISTIN, CYCLOPHOSPHAMIDE AND 5-FLUOROURACIL (AVCF) ADJUVANT TREATMENT OF BREAST-CANCER COMPARED TO TREATMENT WITH CYCLOPHOPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL (CMF)

被引：0
|
作者：
MATHE, G [1 ]
MISSET, JL [1 ]
PLAGNE, R [1 ]
BELPOMME, D [1 ]
LEMEVEL, B [1 ]
GUERRIN, J [1 ]
FUMOLEAU, P [1 ]
METZ, R [1 ]
DELGADO, M [1 ]
DEVASSAL, F [1 ]
ERIGUCHI, M [1 ]
SCHNEIDER, M [1 ]
REIZENSTEIN, P [1 ]
机构：
[1] HOP PAUL BROUSSE,INSERM,INST CANCEROL & IMMUNOGENET,SERV MALAD,SANGUINES & TUMORALES,F-94800 VILLEJUIF,FRANCE
来源：
BREAST CANCER RESEARCH AND TREATMENT | 1985年 / 6卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：168 / 168
页数：1
相关论文
共 50 条
  • [1] ADRIAMYCIN, VINCRISTINE, CYCLOPHOSPHAMIDE AND 5-FLUOROURACIL (AVCF) COMPARED WITH CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL (CMF) IN PREMENOPAUSAL BREAST-CARCINOMA - PERSONAL RESULTS
    MATHE, G
    MISSET, JL
    PLAGNE, R
    REIZENSTEIN, P
    BELPOMME, D
    LEMEVEL, B
    GUERRIN, J
    FUMOLEAU, P
    METZ, R
    DELGADO, M
    DEVASSAL, F
    ERIGUCHI, M
    SCHNEIDER, M
    [J]. DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1986, 12 (1-3) : 143 - 145
  • [2] COMPARISON OF CYCLOPHOSPHAMIDE, ADRIAMYCIN, AND 5-FLUOROURACIL VERSUS CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL IN METASTATIC BREAST-CANCER
    BULL, J
    TORMEY, D
    FALKSON, G
    BLOM, J
    PERLIN, E
    CARBONE, P
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 246 - 246
  • [3] ADRIAMYCIN, CYCLOPHOSPHAMIDE, AND 5-FLUOROURACIL IN TREATMENT OF METASTASIZING BREAST-CANCER
    HOFFKEN, K
    SEEBER, S
    BOECKER, WR
    SCHMIDT, CG
    [J]. ZEITSCHRIFT FUR KREBSFORSCHUNG UND KLINISCHE ONKOLOGIE, 1976, 86 (02): : 135 - 145
  • [4] LOW-DOSE CHEMOTHERAPY OF METASTATIC BREAST-CANCER WITH CYCLOPHOSPHAMIDE, ADRIAMYCIN, METHOTREXATE, 5-FLUOROURACIL (CAMF) VERSUS SEQUENTIAL CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL (CMF) AND ADRIAMYCIN
    CREECH, RH
    CATALANO, RB
    HARRIS, DT
    ENGSTROM, PF
    GROTZINGER, PJ
    [J]. CANCER, 1979, 43 (01) : 51 - 59
  • [5] CLINICAL CONTROLLED TRIAL IN ADVANCED BREAST-CANCER - CMF (CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL) VERSUS CMF+T (CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL, TAMOXIFEN)
    HINDY, I
    [J]. NEOPLASMA, 1985, 32 (03) : 381 - 387
  • [6] Hepatic toxicity during adjuvant cyclophosphamide, methotrexate and 5-Fluorouracil (CMF) in breast cancer
    Noberasco, C
    Peruzzotti, G
    Colleoni, M
    Nole, F
    deBraud, F
    Martinelli, G
    Goldhirsch, A
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 7 - 7
  • [7] Population pharmacokinetics of adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF)
    Batey, MA
    Wright, JG
    Azzabi, A
    Newell, DR
    Lind, MJ
    Calvert, AH
    Boddy, AV
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 (08) : 1081 - 1089
  • [8] ADRIAMYCIN PLUS VINCRISTINE COMPARED TO AND COMBINED WITH CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL FOR ADVANCED BREAST-CANCER
    DELENA, M
    BRAMBILLA, C
    MORABITO, A
    BONADONNA, G
    [J]. CANCER, 1975, 35 (04) : 1108 - 1115
  • [9] A COMPARISON OF CYCLOPHOSPHAMIDE, ADRIAMYCIN, AND 5-FLUOROURACIL (CAF) AND CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL, VINCRISTINE, AND PREDNISONE (CMFVP) IN PATIENTS WITH ADVANCED BREAST-CANCER
    SMALLEY, RV
    LEFANTE, J
    BARTOLUCCI, A
    CARPENTER, J
    VOGEL, C
    KRAUSS, S
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1983, 3 (02) : 209 - 220
  • [10] VARIABILITY IN THE PHARMACOKINETICS OF CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL IN WOMEN RECEIVING ADJUVANT TREATMENT FOR BREAST-CANCER
    MOORE, MJ
    ERLICHMAN, C
    THIESSEN, JJ
    BUNTING, PS
    HARDY, R
    KERR, I
    SOLDIN, S
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 33 (06) : 472 - 476
12345